Hitchcock Family Medicine
JUNE 15, 2023
Getting constant headaches and feeling anxious can be related to a concerning case of stress. Most people have a basic understanding of what feeling stressed is or have experienced its symptoms once in their lifetime. However, as common as it is, it's a considerable mental health issue that affects those with a busy schedule or people with trauma. Stress also has countless misconceptions.
Family Physicians of Greeley
JUNE 16, 2023
Navigating the complexities of insurance and healthcare costs can be overwhelming for patients. Understanding your insurance coverage, managing medical bills, and finding affordable healthcare options are essential for maintaining your health without breaking the bank. In this blog, we will provide you with practical tips to help you navigate insurance and healthcare costs effectively.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PEMBlog
JUNE 14, 2023
We are in the midst of a staggering mental health crisis. Thousands of children and adolescents spend days at time in Emergency Departments waiting for definitive mental health disposition. This podcast episode hosted by Brad Sobolewski ( @PEMTweets ) and co-authored by Dennis Ren ( @DennisRenMD ) is all about what we should consider when boarding children in the ED for mental health reasons.
The Clinical Problem Solvers
JUNE 15, 2023
[link] We continue our campaign to #EndNeurophobia, with the help of Dr. Aaron Berkowitz. This time, Dr. Gabriela Pucci presents a case of right arm weakness to Promise and Ravi. Promise Lee @promiseflee Promise Lee is currently a 3rd year medical student at Loyola University Chicago Stritch School of Medicine. She is an aspiring internal medicine physician with interests in GI, obesity medicine, public health, and clinical reasoning.
Clinical Correlations
JUNE 12, 2023
By Jonah Klapholz Peer Reviewed Telling patients.
FDA Law Blog
JUNE 16, 2023
By Sophia R. Gaulkin & Alan M. Kirschenbaum — On May 24, Minnesota enacted the Commerce and Consumer Protection Omnibus Bill, Senate File 2744 ( SF 2744 ), which significantly expands the state’s existing drug pricing activities with serious implications for all drug manufacturers, and particularly generic drug manufacturers. The drug pricing provisions of SF 2744 establish two mechanisms intended to curb rising drug costs: (1) a prohibition on generic drug manufacturers from taking price in
GeriPal
JUNE 15, 2023
Summary Transcript Summary Artificial Intelligence, or AI, has tremendous potential. We talk on this podcast about potential uses of AI in geriatrics and palliative care with natural language processing guru Charlotta Lindvall from DFCI, bioethicists and internist Matt DeCamp from University of Colorado, and prognosis wizard Sei Lee from UCSF. Social companions to address the epidemic of loneliness among older adults Augmenting ability of clinicians by taking notes Searching the electronic heal
Primary Care Digest brings together the best content for architecture professionals from the widest variety of industry thought leaders.
FDA Law Blog
JUNE 11, 2023
By Mark A. Tobolowsky & David B. Clissold — In May 2023, CDER and CBER published a draft guidance titled “Pediatric Drug Development: Regulatory Considerations – Complying with the Pediatric Research Equity Act [“PREA”] and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act [“BPCA”]” (the “Draft Guidance”). This Draft Guidance, in part, replaces a 2005 guidance titled “How to Comply with the Pediatric Research Equity Act.
FDA Law Blog
JUNE 14, 2023
By Philip Won & Véronique Li, Senior Medical Device Regulation Expert — “Total Product Life Cycle Advisory Program or TAP pilot — the most exciting thing in MDUFA V. This is about reducing the time and cost and increasing the predictability of going from concept to commercialization.” – Dr. Jeff Shuren During a presentation at the May 17, 2023 Food and Drug Law Institute (FDLI) Annual Conference, CDRH Director, Dr.
FDA Law Blog
JUNE 13, 2023
By Jeffrey N. Wasserstein & Dara Katcher Levy — After about a year without any untitled letters from OPDP, Xeris Pharmaceuticals received an untitled letter for their promotion for Recorlev (levoketoconazole) for misleading safety and efficacy claims. To quote everyone’s favorite flautist (and TikTok sensation) Lizzo, “ it’s about d@mn time! ” (Sorry for the bowdlerization, but we’re trying to make it past everyone’s filter and HR warned us in any event.
Expert insights. Personalized for you.
52 
Let's personalize your content